Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Someone posted in another board one of Anavex’s Business directors half naked.
Why would you have to post naked pictures online if you were already involved in the next “blockbuster” drug?
After owning this for 8 years I have a gut feeling what you just posted will happen. All excitement and excellent blown away by hit pieces and the requirement to run a real ph3 that will read until 2028 if we are lucky.
Just like the Parkinson pop, then back down.
Only way out is BP Partnership.
• Sample size might bite us in the rear.
• BP will twist FDA’s arm to require a Real phase 3.
Almost record high Short interest.
They are betting FDA will require a Ph3 with 1500+ patients or it will fail.
Having Macfarlane come to the US is not guarantee of CT success.
Coordinated attack to be held by AF after TLD is released. Might climb to $15-16 premarket and then selloff back to single digits :(
Ouch— not looking good otherwise he would be excited to present
“Know good negotiator”
Guy can even speak fluent English. Give me a 3ffing break.
$100 buyout?
Possibility and reason why Missling asked for MORE options even though stock price has been bleeding for years.
“4) Negotiated good compensation package (good example biochecker).”
He’s the Largest Shareholder and of course voted his millions of Shares for his own salary increase and undeserved options. Never underestimate German Greed.
Thinking he’s looking out for Shareholders is OTC/Microcap Investing mistake 101. Even his business Directors are on perpetual vacations or “working” remote in Europe according to ST.
It’s all about the strike price. The lower the strike price, the higher profits he can achieve if ever successful.
Tying his options to stock price gives him no motivation to PR anything. The lower the price, the better for him.
TLD readout will happen next year amid Full Recession. Other boards are posting how their IG Model Scientists are not even at work.
Wrong.
Missling doesn’t have $hit.
He will be late to everything except his salary raise and undeserved options which he manipulates strike price by not releasing news in a timely manner.
LOL.
Was thinking the same 1066 is 10 years from being anything.
Nothing is guaranteed under Missling, only his options and salary raise.
He might not submit an abstract and screw shareholders like he did with the Avatar phase change fiasco.
Vesting options on Mickey mouse options that incentivize CEO to delay and not even PR news has been a major flag.
I’ve read that many time here
Add Missling’s sloppiness and crazy hair as a recipe for disaster. He won’t deliver anything on time for sure
He did presentation from his Million dollar NY condo. It just had the fake Anavex office background.
People here thinking we have an iceberg in a collision course with BP Amyloid Titanic when it could well be just a floating turd.
PDD OLE catalysts disappearing is no mistake and that’s why longs and insiders have been selling with supposed “we got this” news coming “just around the corner.”
In PDD OLE patients declined after wk 14 like donepezil and Messling is hiding data to soften blow. Market ain’t stupid and that’s why we are single digits
Missing’s voice trembled a little when going over ph2b/3 ALZ readout. Would bet he won’t have TLD this year and no abstract will be submitted before end of September either.
Never put all your eggs in one basket.
“WGT” only applies to the CEO and Board
Which keep milking Shareholders with “just around the corner” and other tactics
SAVA may now buy Anavex for $1B and Missling can retire happy ever after.
Donepezil improved PDD symptoms first 14 weeks and then decline continued.
Anavex did a 14 week study just like the dopenazil and has not shown results due to possible negative results past week 14 therefore Missling chose to hide them until after ALZ TLD
Anavex will never see $1249 at this pace under Missling’s direction.
As a matter of fact $1.249 pre-split is closer every day
Wrong. Fake News
I agree that a ph3 will likely be required especially since the Biogen fiasco. They will want a larger sample size before approving anything in ALZ.
Also Missling is been loading up on more options and higher salary since he knows we still got extra 4-5 years to go. Having extra options lets him sell some to cover his high roller lifestyle in fancy restaurants with his IG models.
Nell Rebowe “neuroscientist” and IG “model” is in Paris right now. I don’t think anything exciting is happening in Anavex’s headquarters.
Little Boston Birdie rumors that AF has next hit piece to be released 15 min after AVXL releases ALZ PR.
We may Never see $20
Again
After 7 years of development this is sitting at $2.455 pre Reverse Split.
Missling’s lack of communication is not helping either and Shorts know this.
No wonder Short Interest increased to 9.1 Million.
Is that Carrot dangling for investors to chase and buy more stock while living the glamorous life in NYC.
Missling is in the Business of Making money, NOT Losing it.
He’s not gonna risk his own money, but ask his peasants for more Options and higher salary which he just got.
This is not trading like the Holy Grail against ALZ.
Smart Money doesn’t want anything to do with Messling and his mishaps.
AF already has hit piece drafted and will send this back to pennyland unfortunately. If this indeed were to be pivotal, then We would be trading at $40 in anticipation of results. Market knows we will need a larger sample size of 1500+ which will delay us back to 2028.
Also it doesn’t help the fact that Missling is perceived as weak and unreliable.
I’ll bet you my Thousands & Thousands of Shares that TLD will NOT Happen in September.
“Fall is getting closer, and AVXL at $1249 getting closer”
Let me fix that for you…
FALLING is getting closer, and AVXL at $12.49 getting farther”
Germans are used to 6-8 weeks PTO every year. Won’t be surprised Missling is out of office until November to check on readout…
High rollover rates are normal since they get paid to do so.
Seen multiple trials fail with HIGH rollover rates.